Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
Third Arc Bio has raised $52.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Third Arc Bio is headquartered in Boston, United States.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
Third Arc Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Third Arc Bio — Funding & Investors." VCBacked, February 4, 2026, https://www.vcbacked.co/company/third-arc-bio. Accessed August 14, 2026.
VCBacked. (2026). Third Arc Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/third-arc-bio
{{cite web |title=Third Arc Bio — Funding & Investors |url=https://www.vcbacked.co/company/third-arc-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated